Loading...
Last update:  December 17, 2017
19:13 +1GMT

Allergenic Molecule  Der p 1Canis familiarisHomo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE1640824.63020100301, Scala E
6.1 - General Population2003BarbadosIgE48126.800
6.2 - General Population (Adults)2012SwedenIgE3711.08020120528, Patelis A
5.3.1 - Source Exposed (Symptoms, IgE)2000TaiwanIgE24843.14020000606, Hu C
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011SingaporeIgE22563.00020110221, Kidon MI
5.1.1 - Source Exposed (Symptoms)2005New ZealandIgE19930.600
3.2.1 - Source Sensitized (IgE)2002BrazilIgE14976.500
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14038.57020130111, Ott H
1.4 - Respiratory Symptoms, Diagnosed2005GermanyIgE13229.500
1.3 - Rhinitis, Diagnosed2003SingaporeIgE12442.700
5.3.2 - Source Exposed (Symptoms, high IgE)2012FranceIgE12392.68020120521, Bronnert M
1.5 - Atopic Dermatitis, Diagnosed2005GermanyIgE11323.000
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2009SpainIgE10699.05020090421, Asturias JA
5.4.2 - Source Exposed (Symptoms, SPT, high IgE)2009SpainSPT10694.33020090421, Asturias JA
1.1 - Asymptomatic2003SingaporeIgE10512.400
5.3.1 - Source Exposed (Symptoms, IgE)2006AustraliaIgE10576.60020060524, Hales BJ
1.5 - Atopic Dermatitis, Diagnosed2014GermanyIgE10082.00020140707, Banerjee S
5.2.1 - Source Exposed (Symptoms, SPT)2011ChinaIgE10094.00020111214, Zheng YW
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9942.42020110223, De Knop KJ
5.1.1 - Source Exposed (Symptoms)2013GermanyIgE9876.53020130501, Becker S
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE962.08020120528, Patelis A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2014ThailandIgE9672.00020140530, Pulsawat P
1.4 - Respiratory Symptoms, Diagnosed2002ThailandSPT9527.400
1.2.1 - Asthma, Diagnosed (Adults)2003MalaysiaIgE9439.000
5.3.1 - Source Exposed (Symptoms, IgE)2007ColombiaIgE9064.40020080220, Jimenez S
5.3.1 - Source Exposed (Symptoms, IgE)1993JapanIgE8890.0001993, Yasueda H
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8615.11020101214, Gadisseur R
1.4 - Respiratory Symptoms, Diagnosed2002ThailandSPT8530.5902002, Trakultivakorn M
5.2.1 - Source Exposed (Symptoms, SPT)2004Australia / AustriaIgE7891.000
5.2.5 - Source Exposed, Children (Symptoms, IgE)2006AustraliaIgE7774.30020060524, Hales BJ
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7628.90020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2014SpainIgE678.90020140625, Armentia A
5.3.1 - Source Exposed (Symptoms, IgE)2008ItalyIgE6790.00020081121, Weghofer M
5.3.1 - Source Exposed (Symptoms, IgE)2008SwedenIgE6585.00020081121, Weghofer M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2011AustriaIgE6283.77020110629, Resch Y
5.3.1 - Source Exposed (Symptoms, IgE)2008AustriaIgE5691.00020081121, Weghofer M
5.3.1 - Source Exposed (Symptoms, IgE)2008FranceIgE55100.00020081121, Weghofer M
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012AustriaIgE5420.40020120310, Twaroch TE
1.1 - Asymptomatic2014SpainIgE500.00020140625, Armentia A
1.9 - Pollen Allergy2014SpainIgE502.00020140625, Armentia A
1.2.2 - Asthma, Diagnosed (Children)2003MalaysiaIgE4957.000
1.4 - Respiratory Symptoms, Diagnosed1994TaiwanSPT4578.000
1.4 - Respiratory Symptoms, Diagnosed2014AustriaIgE4276.00020140707, Banerjee S
5.2.1 - Source Exposed (Symptoms, SPT)2011SpainIgE4077.50020110228, Boquete M
5.2.3 - Source Exposed, Children (Symptoms, SPT)2003MalaysiaIgE4087.500
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3745.94020090826, Ebo DG
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012AustraliaIgE3765.00020121018, Hales BJ
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3522.86020130605, Simon D
5.3.1 - Source Exposed (Symptoms, IgE)1996AustraliaIgE3596.000
5.2.1 - Source Exposed (Symptoms, SPT)2010SpainIgE3281.30020100719, Iraola V
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2008SwedenIgE313.00020081121, Weghofer M
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SingaporeIgE3083.30020100326, Shek LP
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010SingaporeIgE3076.70020100326, Shek LP
10.1 - Normal Control2012BelgiumIgE277.41020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012ItalyIgE269.30020120310, Twaroch TE
5.2.2 - Source Exposed, Adults (Symptoms, SPT)1994AustraliaIgE2623.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012ItalyIgE2696.15020120622, Casset A
5.2.1 - Source Exposed (Symptoms, SPT)2011SpainIgE2539.10020110228, Boquete M
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2231.82020091121, Ebo DG
3.2.1 - Source Sensitized (IgE)2010United StatesIgE2195.23020100315, Mueller GA
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2060.00020091005, Ott H
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2030.00020091121, Ebo DG
5.2.3 - Source Exposed, Children (Symptoms, SPT)1994AustraliaIgE1979.0001994, OBrien RM
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2012FranceIgE1994.73020120622, Casset A
1.5 - Atopic Dermatitis, Diagnosed2014AustriaIgE5100.00020140707, Banerjee S
Developed by
Panservice